Bio Green Med Solution, Inc. is a U.S.-based pharmaceutical preparations company that appears to be in a transition phase following a transaction involving Fitters Sub. The available filings suggest the company is expanding beyond its legacy operations into new markets and operating environments, which is changing its risk profile and internal control requirements. Based on the disclosed risk factors, the business is now focused not only on operating its core activities but also on integrating acquired operations and managing the resulting compliance, governance, and reporting complexity. The company’s public disclosures are sparse, so the profile is driven mainly by its recent 10-Q risk and accounting commentary rather than a detailed product breakdown.
−100,0 %
4.70
3.66
| % | |
|---|---|
| Pharmaceutical preparations | 70% Medicinal and pharmaceutical products and related preparation activities under the company’s core industry classification. |
| Acquired operating business | 20% Operations contributed by Fitters Sub that expand the company into additional markets and operating structures. |
| Compliance and administrative services | 10% Internal compliance, reporting, and control functions required to support regulated operations and integration. |
The company’s direct customers are not described in detail in the available excerpts, but its pharmaceutical...
Buy pharmaceutical preparations and related products that must meet quality, compliance, and documentation requirements.
Customers served through Fitters Sub in markets different from the legacy business, where local rules and operating practices matter.
Buy or distribute products and depend on consistent supply, regulatory compliance, and operational continuity.
The company is headquartered in the United States, but the recent transaction indicates exposure to additional...
The company’s near-term strategy appears centered on integrating Fitters Sub and realizing the expected benefits of the...
The company needs to combine systems, processes, and teams to realize the expected benefits of the acquisition.
A larger and more complex business increases the risk of reporting errors and regulatory scrutiny if controls are weak.
The transaction is intended to broaden the company’s operating footprint and create operational or financial synergies over time.
The most important company-specific risk is execution risk around the Fitters Sub transaction, including integration...
The company says the transaction may not deliver expected benefits if systems, personnel, and operations are not aligned effectively.
Fitters Sub operates in markets with different or more stringent rules, increasing the chance of non-compliance and penalties.
Management explicitly notes higher exposure to security and privacy obligations and the potential for breaches or incidents.
Integrating a new business increases the complexity of controls and the risk of errors, restatements, or audit issues.
The acquired business may carry tax, legal, environmental, employment, or warranty liabilities not fully identified in due diligence.
GPLB · Biological Products, (No Diagnostic Substances)
Green Planet Bio Engineering Co.
BIXT · Pharmaceutical Preparations
BHIC · Services-Computer Processing & Data Preparation
GRML · Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd is a U.S.-based development-stage life sciences company that has not yet generated operating revenue.
BIOE · Pharmaceutical Preparations
Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services.
ASBP · Pharmaceutical Preparations
: 11/08/2026